Company: Sarepta Therapeutics
Posted by SareptaRep_NewEngland_2245 · March 19, 2026
Tags: launch, strategy, field
after the ESSENCE miss and months of uncertainty — FDA confirmed we can submit using 9-year data plus real world evidence.
they're not pulling the approvals.
spent Q4 having really hard conversations.
this is the first good news in a while.
not guaranteed but having a path matters.
13 upvotes · 5 comments